UiPath Future Growth
Future criteria checks 1/6
UiPath's earnings are forecast to decline at 23.6% per annum while its annual revenue is expected to grow at 8.1% per year. EPS is expected to decline by 1.7% per annum. Return on equity is forecast to be 20.1% in 3 years.
Key information
-23.6%
Earnings growth rate
-1.74%
EPS growth rate
| Software earnings growth | 18.7% |
| Revenue growth rate | 8.1% |
| Future return on equity | 20.08% |
| Analyst coverage | Good |
| Last updated | 17 Apr 2026 |
Recent future growth updates
Recent updates
PATH: Agentic AI Automation And ARR Stability Will Drive Future Upside
Analysts have reduced UiPath's average price target by a few dollars to a roughly mid-teens dollar value. They cite solid Q4 execution and ARR trends, but also point to valuation compression across software peers, along with a need for clearer AI monetization and sustained net new ARR growth.PATH: Agentic AI Automation And ARR Stability Will Support Future Upside
Analysts have nudged the average price target for UiPath slightly lower to around the mid teens in $ terms, trimming expectations on valuation multiples, even as they cite solid Q4 execution, steady ARR trends and growing interest in AI driven automation as key supports for the story. Analyst Commentary Recent research points to a mixed but generally balanced view on UiPath, with most firms trimming price targets while acknowledging solid Q4 execution, resilient ARR and growing interest in AI driven automation.UiPath: With Meaningful ARR Growth, This Company Has True AI Tailwinds
Apr 02PATH: Agentic AI Automation And Healthcare Solutions Will Support Future Upside
UiPath's updated analyst fair value estimate has shifted from $15.93 to $13.81 as analysts reset price targets across the $12 to $18 range, weighing solid Q4 execution, AI driven automation traction and improving margins against valuation compression, flat to stabilizing net new ARR, and the need for clearer proof of sustained AI monetization. Analyst Commentary Recent research points to a split view on UiPath, with most firms reducing price targets but highlighting both encouraging execution in Q4 and unresolved questions around future growth and valuation.
AI Automation Platform Will Benefit From Long Term Cross System Workflow Complexity
Catalysts About UiPath UiPath provides an end to end automation and AI platform that helps enterprises automate complex workflows across systems, people and software. What are the underlying business or industry changes driving this perspective?
UiPath Inc. (PATH): Agentic AI Pivot and Milestone Profits Set the Stage for Q4 Results
UiPath is currently undergoing a fundamental evolution from a traditional Robotic Process Automation (RPA) provider into a comprehensive "Agentic AI" platform. Trading at $11.60 as of the March 10, 2026, close, the stock dipped 3.1% today as the market maintains a cautious "wait-and-see" stance ahead of its fiscal year-end report.PATH: Healthcare AI Launch And Index Additions Will Support Future Upside
Analysts have trimmed their blended price target for UiPath by about $0.27 to reflect a slightly lower fair value estimate of $15.93, modestly higher discount rate assumptions, and only small tweaks to long term margin and P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts see scope for UiPath to reach a price target of US$18, which sits above the trimmed blended fair value estimate of US$15.93, suggesting room for upside if execution aligns with their assumptions.PATH: Index Additions And Buybacks Will Support Future Automation Upside
Analysts have trimmed their UiPath fair value estimate slightly to $16.19 from $16.40, citing mixed expectations around future profitability and valuation multiples, even as revenue assumptions stay relatively steady. Analyst Commentary Street research on UiPath reflects a mix of optimism around sector conditions and caution around how that translates into the company’s valuation and execution over time.Some Confidence Is Lacking In UiPath, Inc. (NYSE:PATH) As Shares Slide 30%
Feb 06
PATH: AI Software Setup And Index Adds Will Support Automation Outlook
Narrative Update on UiPath UiPath’s implied analyst price target has ticked higher as recent research cites a move from $16 to $18 at one firm and from $12 to $14 at another, with analysts pointing to a generally supportive backdrop for software and ongoing interest in AI related opportunities as key drivers for the updated views. Analyst Commentary Recent research on UiPath centers on how the shares might reflect a mixed backdrop for software, AI related themes, and current valuation levels.PATH: AI Software Setup And Index Adds Will Support Automation Outlook
Narrative update Analysts have nudged their fair value view for UiPath slightly higher, reflecting price target moves such as Barclays lifting its target to US$18 from US$16 and RBC Capital moving to US$14 from US$12, citing a more constructive setup for software and AI exposed names. Analyst Commentary Recent research is broadly constructive, but it also highlights that expectations around AI and software can still be a source of swings in sentiment for UiPath.PATH: AI Trade Enthusiasm And Index Adds Will Shape Automation Outlook
Analysts have inched their fair value estimate for UiPath lower from $16.40 to about $16.27 per share, while still lifting some price targets, such as the move to $14 at RBC Capital. This reflects mixed views as they weigh AI related enthusiasm against updated assumptions for growth, margins and future P/E multiples.UiPath Inc.'s (NYSE:PATH) 28% Price Boost Is Out Of Tune With Revenues
Dec 23PATH: AI Partnerships Will Support Automation Gains While Competition Keeps Outlook Balanced
Analysts have modestly increased their fair value estimate for UiPath from approximately $15.93 to $16.40 per share, reflecting a slightly higher long term growth outlook supported by recent price target raises tied to AI driven product enhancements and partnerships, despite ongoing competitive pressures. Analyst Commentary Recent Street commentary reflects a cautiously constructive stance on UiPath, with modest target price increases framed by both optimism around AI driven automation and recognition of intense competitive dynamics.PATH: AI Partnerships Will Drive Automation Hype Yet Leave Shares Vulnerable
UiPath's updated fair value estimate has risen to approximately $15.93 from $13.86, as analysts modestly lift price targets in response to new product launches, strategic partnerships, and expectations that the company can increasingly leverage AI trends, despite a still competitive market. Analyst Commentary Analysts remain measured on UiPath, modestly increasing price targets while keeping neutral ratings as they weigh improving product momentum against a still challenging competitive backdrop.PATH: Partnerships And New AI Offerings Will Shape Automation Leadership Ahead
Analysts have modestly increased their price target for UiPath, raising it from approximately $13.71 to $13.86 per share. They cite recent product updates and ongoing developments in the AI and automation space as supportive factors for the adjustment.PATH: Product Partnerships And Updates Will Shape Future Opportunities In Automation
UiPath's analyst price target has increased to $13 from $12.50, as analysts recognize ongoing product updates and partnerships but remain cautious about the company's growth prospects in a competitive market. Analyst Commentary Recent analyst updates reflect a nuanced perspective on UiPath's future, highlighting both supportive and cautious sentiments about the company's execution and long-term growth prospects.Expanding Automation Partnerships And AI-Powered Agents Will Drive Business Momentum
UiPath’s analyst price target has been revised upward to $13 from $12.50, as analysts cite ongoing product innovation and new partnerships. This comes despite expectations of gradual top-line impact amid ongoing market competition.Agent Builder And Agentic Orchestration Will Expand Market Opportunities
UiPath’s analyst price target has been modestly increased from $13.30 to $13.44, as analysts cite ongoing product and partnership developments. However, they also note persistent competitive pressures in the automation market.What UiPath Inc.'s (NYSE:PATH) 26% Share Price Gain Is Not Telling You
Oct 07Agent Builder And Agentic Orchestration Will Expand Market Opportunities
UiPath’s price target has been revised down due to a sharp year-over-year decline in net new ARR and heightened long-term market uncertainty, reflecting a lowered fair value from $14.15 to $13.30. Analyst Commentary Net new annual recurring revenue rose by $30M, but this represents a 30% year-over-year decline.When Should You Buy UiPath Inc. (NYSE:PATH)?
Jul 23UiPath's Oversold Status Triggers Cheap Buying Opportunity - Maintain Buy
Apr 16The Drop In UiPath Stock Unlocks Long-Term Potential
Mar 21
Agent Builder And Agentic Orchestration Will Expand Market Opportunities
Strategic partnerships and innovation in automation aim to boost growth through deeper customer relationships and expanded market opportunities.UiPath Stock Is A Buy On The Technical Weakness
Mar 04UiPath: AI Potential Vs. Margin Reality (Rating Downgrade)
Feb 26UiPath: The Value Keeps Getting Better As This Company Builds AI Agents
Jan 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 1/31/2029 | 2,053 | N/A | 510 | N/A | 5 |
| 1/31/2028 | 1,905 | 193 | 483 | 497 | 20 |
| 1/31/2027 | 1,758 | 153 | 425 | 435 | 19 |
| 1/31/2026 | 1,611 | 282 | 352 | 371 | N/A |
| 10/31/2025 | 1,553 | 230 | 312 | 335 | N/A |
| 7/31/2025 | 1,497 | 20 | 310 | 335 | N/A |
| 4/30/2025 | 1,451 | -68 | 313 | 340 | N/A |
| 1/31/2025 | 1,430 | -74 | 306 | 321 | N/A |
| 10/31/2024 | 1,411 | -92 | 309 | 320 | N/A |
| 7/31/2024 | 1,383 | -112 | 327 | 334 | N/A |
| 4/30/2024 | 1,354 | -87 | 325 | 332 | N/A |
| 1/31/2024 | 1,308 | -90 | 292 | 299 | N/A |
| 10/31/2023 | 1,211 | -151 | 242 | 247 | N/A |
| 7/31/2023 | 1,148 | -178 | 168 | 178 | N/A |
| 4/30/2023 | 1,103 | -238 | 94 | 110 | N/A |
| 1/31/2023 | 1,059 | -328 | -34 | -10 | N/A |
| 10/31/2022 | 1,040 | -364 | -135 | -110 | N/A |
| 7/31/2022 | 998 | -429 | -132 | -108 | N/A |
| 4/30/2022 | 951 | -408 | -109 | -90 | N/A |
| 1/31/2022 | 892 | -526 | -67 | -55 | N/A |
| 10/31/2021 | 810 | -436 | -42 | -31 | N/A |
| 7/31/2021 | 737 | -384 | -5 | 2 | N/A |
| 4/30/2021 | 681 | -284 | 30 | 36 | N/A |
| 1/31/2021 | 608 | -92 | 26 | 29 | N/A |
| 1/31/2020 | 336 | -520 | -380 | -359 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PATH's earnings are forecast to decline over the next 3 years (-23.6% per year).
Earnings vs Market: PATH's earnings are forecast to decline over the next 3 years (-23.6% per year).
High Growth Earnings: PATH's earnings are forecast to decline over the next 3 years.
Revenue vs Market: PATH's revenue (8.1% per year) is forecast to grow slower than the US market (11% per year).
High Growth Revenue: PATH's revenue (8.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PATH's Return on Equity is forecast to be high in 3 years time (20.1%)
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/30 16:19 |
| End of Day Share Price | 2026/04/30 00:00 |
| Earnings | 2026/01/31 |
| Annual Earnings | 2026/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
UiPath, Inc. is covered by 31 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raimo Lenschow | Barclays |
| William Kingsley Crane | Berenberg |
| Keith Bachman | BMO Capital Markets Equity Research |